STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		47,260,108
Beginning balance at Dec. 31, 2023	$ 144,705	$ 5	$ 451,006	$ 4	$ (306,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)		336,005
Exercise of stock options and purchases pursuant to employee stock purchase plan	1,255		1,255
Issuance of common stock upon settlement of restricted stock units (in shares)		164,153
Taxes paid related to net share settlement of restricted stock unit (in shares)		(45,558)
Taxes paid related to net share settlement of restricted stock units	(451)		(451)
Stock-based compensation expense	9,546		9,546
Proceeds from sale of common stock	(17)		(17)
Unrealized gain (loss) on investments	(2)			(2)
Net loss	(75,410)				(75,410)
Ending balance (in shares) at Dec. 31, 2024		47,714,708
Ending balance at Dec. 31, 2024	79,626	$ 5	461,339	2	(381,720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)		30,275
Exercise of stock options and purchases pursuant to employee stock purchase plan	25		25
Issuance of common stock upon settlement of restricted stock units (in shares)		236,051
Taxes paid related to net share settlement of restricted stock unit (in shares)		(54,403)
Taxes paid related to net share settlement of restricted stock units	(65)		(65)
Stock-based compensation expense	6,995		6,995
Proceeds from sale of common stock, pre-funded warrants and common stock warrants, net of offering costs (in shares)		15,225,158
Proceeds from sale of common stock, pre-funded warrants and common stock warrants, net of offering costs	44,475	$ 2	44,473
Exercise of common stock warrants (in shares)		128,054
Exercise of common stock warrants	139		139
Unrealized gain (loss) on investments	4			4
Net loss	(48,809)				(48,809)
Ending balance (in shares) at Dec. 31, 2025		63,279,843
Ending balance at Dec. 31, 2025	$ 82,390	$ 7	$ 512,906	$ 6	$ (430,529)